Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways.
about
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.Role of steroid hormones and growth factors in breast cancer.SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatmentNew cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancerAurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells.Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell linesNADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast CancerPropagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsA kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, aromatase, estrogen, and androgen activity.Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
P2860
Q27852459-BE0E5247-4684-49A9-9140-79C87D0F165AQ35023097-8904964E-BA55-46ED-AA30-31146EE9476FQ35113027-B17CD44A-3A5E-44BD-9AB6-C3823A15CA42Q35168124-FEBBABF8-9764-4D83-A361-025EE52A593BQ35356178-081BDB3D-F39D-41F0-80E8-C6E3B8D2B1A9Q35558610-4CD5B6E1-FA07-4298-A40C-180B9289C1F8Q35880182-40600585-4952-4CCF-B99D-D6C2C2D08576Q36263042-60AF0A5C-2C77-4974-8623-5C85C224B24DQ36320380-92457B31-3F4C-47B5-8EEB-20CEA1E908EFQ37525906-63F80C89-9908-4D48-87BA-774EA8EDCF7BQ38943401-A55C85D5-809E-4B5C-B477-C9975A64D2AFQ39360262-3398EB8D-599D-48E9-A686-9E3610FD0D7DQ39756962-32BC0167-56B2-4628-AD85-131AC5BCC634Q40565025-8EF3631E-1FD3-4101-92E9-68EB87D5ECE1Q51051063-2322F22C-EA3A-4D9A-9D60-86D79BB03387Q55298688-4ED93370-C1D1-41C8-938C-F47519587C8C
P2860
Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Growth inhibition and growth s ...... es involve different pathways.
@en
type
label
Growth inhibition and growth s ...... es involve different pathways.
@en
prefLabel
Growth inhibition and growth s ...... es involve different pathways.
@en
P2093
P356
P1476
Growth inhibition and growth s ...... es involve different pathways.
@en
P2093
Lundholt BK
Lykkesfeldt AE
P2888
P304
P356
10.1023/A:1017977406429
P407
P577
2001-06-01T00:00:00Z
P6179
1046521999